4.6 Article

Genome-wide association study and functional validation implicates JADE1 in tauopathy

期刊

ACTA NEUROPATHOLOGICA
卷 143, 期 1, 页码 33-53

出版社

SPRINGER
DOI: 10.1007/s00401-021-02379-z

关键词

-

资金

  1. Rainwater Charitable Foundation [IMSSM: R01 AG054008, R01 NS095252, R01 AG060961, R01 NS086736]
  2. Genentech/Roche
  3. Alexander Saint-Amand Fellowship (JFC) [F32 AG056098, P50 AG005138, P30 AG066514, 75N95019C00049, K99 AG070109, U01 AG058635]
  4. Arizona Department of Health Services [U24 NS072026, P30 AG019610]
  5. Michael J. Fox Foundation for Parkinson's Research
  6. Johns Hopkins [P50 AG05146]
  7. U Iowa [K23 NS109284]
  8. Roy J. Carver Foundation
  9. Carver College of Medicine
  10. Williams-Cannon Foundation (MMH), Northwestern [P30 AG013854]
  11. Emory [P30 NS055077, P50 AG025688]
  12. OHSU [P30 AG08017]
  13. UTSW: Winspear Family Center for Research on the Neuropathology of Alzheimer Disease (CWIII)
  14. Toronto: Rossy Foundation
  15. Safra Foundation (GGK)
  16. Stanford [R01AG059848]
  17. MADRC [P50 AG05134, P30 AG062421]
  18. RUSH [AG10161]
  19. MAP
  20. UCI [R01AG021055, P50AG016573, P01AG000538]
  21. UCSD [P30 AG062429 01, P50 AG005131]
  22. UK [P30 AG028383]
  23. U Washington [P50 AG005136, P30 AG066509, U01 AG006781, U19 066567]
  24. Nancy and Buster Alvord Endowment
  25. Washington U/Knight ADRC [P30 AG066444, P01 AG003991, 01 AG026276]
  26. Newcastle: UK Medical Research Council [G0400074]
  27. Brains for Dementia research
  28. Alzheimer's Society
  29. Alzheimer's Research UK
  30. NIHR Newcastle Biomedical Research Centre
  31. Newcastle University
  32. J.M.R. Barker Foundation
  33. McCune Foundation
  34. BU/MSSM/MAYO [R01 AG062348]
  35. UMC [P50AG008702]
  36. BU [U54 NS115266, R01 CA079830]
  37. UPENN [30 AG010124, P01 AG017586, U19 AG062418, P30 AG072979, P01 AG066597, R01 AG066152]
  38. PITT [R01 AG066152 P30 AG066468]
  39. MRC [G0400074] Funding Source: UKRI

向作者/读者索取更多资源

The study found that Primary age-related tauopathy (PART) has a genetic architecture that partially overlaps with Alzheimer's disease (AD) and other tauopathies, and suggests a novel role for JADE1 as a modifier of neurofibrillary degeneration.
Primary age-related tauopathy (PART) is a neurodegenerative pathology with features distinct from but also overlapping with Alzheimer disease (AD). While both exhibit Alzheimer-type temporal lobe neurofibrillary degeneration alongside amnestic cognitive impairment, PART develops independently of amyloid-beta (A beta) plaques. The pathogenesis of PART is not known, but evidence suggests an association with genes that promote tau pathology and others that protect from A beta toxicity. Here, we performed a genetic association study in an autopsy cohort of individuals with PART (n = 647) using Braak neurofibrillary tangle stage as a quantitative trait. We found some significant associations with candidate loci associated with AD (SLC24A4, MS4A6A, HS3ST1) and progressive supranuclear palsy (MAPT and EIF2AK3). Genome-wide association analysis revealed a novel significant association with a single nucleotide polymorphism on chromosome 4 (rs56405341) in a locus containing three genes, including JADE1 which was significantly upregulated in tangle-bearing neurons by single-soma RNA-seq. Immunohistochemical studies using antisera targeting JADE1 protein revealed localization within tau aggregates in autopsy brains with four microtubule-binding domain repeats (4R) isoforms and mixed 3R/4R, but not with 3R exclusively. Co-immunoprecipitation in post-mortem human PART brain tissue revealed a specific binding of JADE1 protein to four repeat tau lacking N-terminal inserts (0N4R). Finally, knockdown of the Drosophila JADE1 homolog rhinoceros (rno) enhanced tau-induced toxicity and apoptosis in vivo in a humanized 0N4R mutant tau knock-in model, as quantified by rough eye phenotype and terminal deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL) in the fly brain. Together, these findings indicate that PART has a genetic architecture that partially overlaps with AD and other tauopathies and suggests a novel role for JADE1 as a modifier of neurofibrillary degeneration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据